Novartis Investigative Site is a clinical research site located in Spokane, Washington, United States 99202.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 35 clinical trials.
Therapeutic areas: Relapsing Multiple Sclerosis, Heart Failure and Reduced Ejection Fraction, Pseudomonas Aeruginosa in Cystic Fibrosis.
Sponsors: Novartis Pharmaceuticals, Mylan Inc., Novartis.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Spokane
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 35 clinical trials on record. Their work covers Relapsing Multiple Sclerosis, Heart Failure and Reduced Ejection Fraction, Pseudomonas Aeruginosa in Cystic Fibrosis.
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.